2. Academic Validation
  3. Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: Therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury

Identification of novel dynamin-related protein 1 (Drp1) GTPase inhibitors: Therapeutic potential of Drpitor1 and Drpitor1a in cancer and cardiac ischemia-reperfusion injury

  • FASEB J. 2020 Jan;34(1):1447-1464. doi: 10.1096/fj.201901467R.
Danchen Wu 1,  Asish Dasgupta 1,  Kuang-Hueih Chen 1,  Monica Neuber-Hess 1,  Jignesh Patel 2,  Timothy E Hurst 2,  Jeffrey D Mewburn 1,  Patricia D A Lima 3,  Elahe Alizadeh 3,  Ashley Martin 1,  Michael Wells 4,  Victor Snieckus 2,  Stephen L Archer 1
Affiliations

Affiliations

  • 1 Department of Medicine, Queen's University, Kingston, ON, Canada.
  • 2 Department of Chemistry, Queen's University, Kingston, ON, Canada.
  • 3 Queen's Cardiopulmonary Unit (QCPU), Translational Institute of Medicine (TIME), Department of Medicine, Queen's University, Kingston, ON, Canada.
  • 4 Office of Partnerships and Innovation, Queen's University, Kingston, ON, Canada.
PMID: 31914641 DOI: 10.1096/fj.201901467R
Abstract

Mitochondrial fission is important in physiological processes, including coordination of mitochondrial and nuclear division during mitosis, and pathologic processes, such as the production of Reactive Oxygen Species (ROS) during cardiac ischemia-reperfusion injury (IR). Mitochondrial fission is mainly mediated by dynamin-related protein 1 (Drp1), a large GTPase. The GTPase activity of Drp1 is essential for its fissogenic activity. Therefore, we aimed to identify Drp1 inhibitors and evaluate their anti-neoplastic and cardioprotective properties in five Cancer cell lines (A549, SK-MES-1, SK-LU-1, SW 900, and MCF7) and an experimental cardiac IR injury model. Virtual screening of a chemical library revealed 17 compounds with high predicted affinity to the GTPase domain of Drp1. In silico screening identified an ellipticine compound, Drpitor1, as a putative, potent Drp1 inhibitor. We also synthesized a congener of Drpitor1 to remove the methoxymethyl group and reduce hydrolytic lability (Drpitor1a). Drpitor1 and Drpitor1a inhibited the GTPase activity of Drp1 without inhibiting the GTPase of Dynamin 1. Drpitor1 and Drpitor1a have greater potency than the current standard Drp1 GTPase inhibitor, mdivi-1, (IC50 for mitochondrial fragmentation are 0.09, 0.06, and 10 μM, respectively). Both Drpitors reduced proliferation and induced Apoptosis in Cancer cells. Drpitor1a suppressed lung Cancer tumor growth in a mouse xenograft model. Drpitor1a also inhibited mitochondrial ROS production, prevented mitochondrial fission, and improved right ventricular diastolic dysfunction during IR injury. In conclusion, Drpitors are useful tools for understanding mitochondrial dynamics and have therapeutic potential in treating Cancer and cardiac IR injury.

Keywords

breast cancer; ellipticine; lung cancer; mitochondrial division inhibitor 1 (mdivi‐1); mitochondrial dynamics; mitochondrial fission; right ventricle.

Figures
Products